Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy

Sponsor
Connecticut Children's Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT00863070
Collaborator
(none)
6
2
47
3
0.1

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether patients who have undergone exstrophy closure may be at risk for long-term orthopedic issues manifest by gait abnormalities. This study is a descriptive analysis of the study cohort's gait patterns and pelvic structure.

Specific Aim 1: to determine whether patients with classic bladder exstrophy who underwent closure demonstrate gait abnormalities.

Hypothesis 1: Patients undergoing closure of bladder exstrophy (with or without pelvic osteotomy) demonstrate gait abnormalities compared with a reference population.

Hypothesis 2: Patients undergoing closure of bladder exstrophy (with or without pelvic osteotomy) will have below normal functional survey scores.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    6 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
    Study Start Date :
    Apr 1, 2009
    Actual Primary Completion Date :
    Mar 1, 2013
    Actual Study Completion Date :
    Mar 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    Bladder Exstrophy Patients

    Patients who receive follow-up care at Connecticut CMC urology clinic for bladder exstrophy.

    Outcome Measures

    Primary Outcome Measures

    1. Gait Testing and Analysis [2 Weeks]

    Secondary Outcome Measures

    1. Demographic Data:age;GA at birth; Prenatal DX;closure age;Pelvic osteotomies;Perioperative and late complications;Successful initial closure;Continence; Additional surgeries w/age [2 weeks]

    2. Pediatric Outcomes Data Collection Instrument (PODCI) [2 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    4 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Subject was seen at CCMC for bladder exstrophy between January 2002 and December 2010.

    2. Subject is four years of age or older at time of enrollment.

    3. Subject has the ability to walk.

    4. Subject has not had gait testing performed.

    5. Subject provides Informed Consent and HIPAA Authorization.

    Exclusion Criteria:
    1. Subject was not seen at CCMC for bladder exstrophy between January 2002 and December

    2. Subject under four years of age at time of enrollment.

    3. Subject does not have the ability to walk.

    4. Subject had prior gait testing performed.

    5. Subject not willing to provide Informed Consent and HIPAA Authorization.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Center for Motion Analysis Farmington Connecticut United States 06032
    2 Connecticut Children's Medical Center Hartford Connecticut United States 06106

    Sponsors and Collaborators

    • Connecticut Children's Medical Center

    Investigators

    • Study Director: Katherine W Herbst, M.Sc, Connecticut Children's Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Connecticut Children's Medical Center
    ClinicalTrials.gov Identifier:
    NCT00863070
    Other Study ID Numbers:
    • 09-003
    First Posted:
    Mar 17, 2009
    Last Update Posted:
    Mar 20, 2017
    Last Verified:
    Mar 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Connecticut Children's Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 20, 2017